Trials / Conditions / Symptomatic Aortic Stenosis

Symptomatic Aortic Stenosis

23 registered clinical trials studyying Symptomatic Aortic Stenosis — 4 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	DurAVR™ THV EU-EFS NCT06510855	Anteris Technologies Ltd.	N/A
Active Not Recruiting	Use of DurAVR™ THV System in Subjects With Severe Aortic Stenosis: Early Feasibility Study NCT05712161	Anteris Technologies Ltd.	N/A
Recruiting	Pivotal Study of the Vienna Transcatheter Self Expandable Aortic Valve SE System NCT04861805	P+F Products + Features GmbH	N/A
Recruiting	Structured Shared Decision Making for Patients Undergoing SAVR or TAVR NCT05711186	Insel Gruppe AG, University Hospital Bern	N/A
Unknown	DurAVR™ THV System: First-In-Human Study NCT05182307	Anteris Technologies Ltd.	N/A
Active Not Recruiting	SMall Annuli Randomized To Evolut™ or SAPIEN™ Trial NCT04722250	Medtronic Cardiovascular	N/A
Completed	Platelet REACtivity According to TICagrelor Dose After Transcatheter AorticValve Implantation NCT04331145	Andres Iñiguez Romo	Phase 4
Completed	Optimize PRO Study NCT04091048	Medtronic Cardiovascular	—
Completed	China S3: Safety and Effectiveness of Edwards Lifesciences SAPIEN 3 THV in the Chinese Population NCT03466918	Edwards Lifesciences	N/A
Completed	China XT: Safety and Effectiveness of Edwards Lifesciences SAPIEN XT THV in the Chinese Population NCT03314857	Edwards Lifesciences	N/A
Withdrawn	Image Fusion and Calcification Raising in Trans Aortic Valve Implantation NCT03247465	Nantes University Hospital	N/A
Completed	Anti-Thrombotic Strategy After Trans-Aortic Valve Implantation for Aortic Stenosis NCT02664649	Assistance Publique - Hôpitaux de Paris	Phase 3
Recruiting	Transcatheter Aortic Valve Replacement Single Center Registry in Chinese Population NCT02803294	Second Affiliated Hospital, School of Medicine, Zhejiang University	Phase 4
Completed	The REFLECT Trial: Cerebral Protection to Reduce Cerebral Embolic Lesions After Transcatheter Aortic Valve Imp NCT02536196	Keystone Heart	N/A
Terminated	The Medtronic Transcatheter Aortic Valve Implant System (CoreValve System Family) Post Marketing Surveillance NCT02759237	Medtronic Cardiovascular	—
Completed	Geriatric Evaluation to Predict Mortality and Functional Recovery After Trans Aortic Valve Implantation NCT02424370	Assistance Publique - Hôpitaux de Paris	—
Withdrawn	Assessment of the St. Jude Medical PorticoTM Re-sheathable Aortic Valve System - Alternative Access NCT02088021	Abbott Medical Devices	N/A
Completed	Women's INternational Transcatheter Aortic Valve Implantation Registry NCT01819181	Icahn School of Medicine at Mount Sinai	—
Completed	Portico TAVI Implant With Transfemoral Delivery System NCT01493284	Abbott Medical Devices	N/A
Completed	ACURATE TA™ Valve Implantation: SAVI Registry (Surveillance Plan #2011-02) (TA-SAVI) NCT03143686	Symetis SA	—
Completed	ACURATE TF™ Transfemoral Aortic Bioprosthesis for Implantation in Patients With Severe Aortic Stenosis:CE-appr NCT03003650	Symetis SA	N/A
Completed	First in Human Experience of the St. Jude Medical TAVI Valve and Delivery System NCT01487330	Abbott Medical Devices	N/A
Unknown	Severe Aortic Stenosis in Patients Referred for Valve Surgery NCT01794832	Oslo University Hospital	—